Pimecrolimus and Skin Cancer Risk: What You Need to Know
Pimecrolimus, commonly used to treat eczema, has been under scrutiny for its potential to increase skin cancer risk. While some studies suggest a link, it's not yet conclusive. It's essential for patients using Pimecrolimus to discuss their concerns with their healthcare provider. Regular skin checks and sun protection can help manage potential risks. Always remember, your health is paramount, so don't hesitate to ask questions or seek second opinions.
Read More